The Fetal Cell Banking team is dedicated to developing regenerative neural stem
cell therapies for diseases of the central nervous system (CNS).

Neural stem/progenitor cells (NSPCs) have been studied for many decades and
proved to be effective tools in CNS regenerative therapy through non-clinical and clinical trials.
Human fetal-derived neural stem/progenitor cells (NSPCs) can promote regeneration by
producing high levels of trophic factors and replacing damaged cells.

Using these rationales, our team has isolated NSPCs from donated human fetus and
evaluated their regenerative function through in vitro/in vivo test.
As a result, our team will develop fetal cell banking system and therapeutics
for the treatment of CNS diseases.